Single Nanochannel Platform for Detecting Chiral Drugs

Anal Chem. 2017 Jan 17;89(2):1110-1116. doi: 10.1021/acs.analchem.6b02682. Epub 2016 Dec 22.

Abstract

Chiral drugs play an essential role in medical and biochemical systems, and thus enantioselective analysis of chiral molecules has become a central focus in chemical, biological, medical, and pharmaceutical research. The design of chiral drug-detecting systems is a long-term and challenging task. Here we report the use of a modification-free nanochannel method for enantioselective recognition of S-naproxen from R-naproxen using N-acetyl-l-cysteine-capped gold nanoparticles as a chiral selector. The chiral discrimination is based on a drug-induced nanoparticle diastereoselective aggregation mechanism that blocks ion transport through the nanochannel. We demonstrated that high S-Npx selectivity in both water and biological samples can be achieved. This simple method has potential applications as a general platform for the detection of chiral molecules.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / chemistry
  • Anti-Inflammatory Agents, Non-Steroidal / chemistry*
  • Anti-Inflammatory Agents, Non-Steroidal / isolation & purification
  • Dimerization
  • Equipment Design
  • Gold / chemistry*
  • Metal Nanoparticles / chemistry*
  • Metal Nanoparticles / ultrastructure
  • Nanotechnology / instrumentation
  • Naproxen / chemistry*
  • Naproxen / isolation & purification
  • Stereoisomerism

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Naproxen
  • Gold
  • Acetylcysteine